# Matching Perfusion and Metabolic Activity in HFpEF

> **NCT04913805** · PHASE2 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 53 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Potassium Nitrate
- **DRUG:** Potassium Nitrate + Propionyl-L-Carnitine + Nicotinamide Riboside
- **OTHER:** Potassium Chloride

## Key facts

- **NCT ID:** NCT04913805
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-11
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913805, "Matching Perfusion and Metabolic Activity in HFpEF". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04913805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*